Krabeva 100 mg Injection

Get a Price/Quote

MOQ : 35 Pieces

Krabeva 100 mg Injection Specification

Origin of Medicine
INDIA

Physical Form
Liquid

Recommended For
DOCTOR

Quantity
35 Pieces

Marketed By
Biocon Biologics

Route
IV use only

Color
Clear solution

Prescription
Required

Vial Size
4 ml

Strength
100 mg

Krabeva 100 mg Injection Trade Information

Minimum Order Quantity
35 Pieces

Delivery Time
1 Week

About Krabeva 100 mg Injection

Krabeva 100 mg Injection is a targeted therapy used in the treatment of various types of cancer, including colorectal cancer, non-small cell lung cancer, glioblastoma, kidney cancer, and ovarian cancer. This medication contains Bevacizumab, a monoclonal antibody that effectively inhibits vascular endothelial growth factor (VEGF), a protein that promotes the growth of blood vessels that tumors need to thrive. By blocking VEGF, Krabeva helps to starve tumors of their blood supply, ultimately slowing their growth and spread. Patients receiving this injection may experience side effects such as high blood pressure or bleeding, and regular monitoring by healthcare professionals is essential to ensure safety and efficacy during treatment. It is important to inform your doctor about any existing health conditions or medications you are taking, as these can influence the effectiveness and safety of Krabeva. Administered alongside other cancer therapies, Krabeva 100 mg Injection represents a vital component of modern oncological treatment strategies. Always consult your healthcare provider for personalized advice and to discuss the potential benefits and risks associated with this innovative cancer therapy.

Targeted Applications for Healthcare Needs

Krabeva 100 mg Injection is specifically designed for administration by licensed doctors in hospital setups. Its IV route provides rapid delivery and optimal absorption, catering to acute medical requirements. Distributors and suppliers benefit from its clear solution, as it demonstrates quality standards, aiding in efficient distribution to health facilities across India.

Quality Assurance and Safe Usage

Manufactured by Biocon Biologics, Krabeva confirms its reliability with high purity and stringent production protocols for liquid pharmaceuticals. Its clear, transparent appearance indicates optimal preparation, and prescription control guarantees that only authorized professionals use the product, securing both safety and compliance with medical regulations.

FAQ's of Krabeva 100 mg Injection:

Q: How should Krabeva 100 mg Injection be administered to patients?

A: Krabeva 100 mg Injection is intended for intravenous (IV) use only, meaning it must be administered directly into a vein by a qualified medical professional, such as a doctor in a clinical setting.

Q: What is the physical appearance and composition of the Krabeva 100 mg Injection?

A: The injection is a clear liquid solution supplied in a 4 ml vial, featuring a dosage strength of 100 mg. Its appearance helps ensure quality and usability for medical purposes.

Q: When should Krabeva 100 mg Injection be used?

A: Krabeva 100 mg Injection should be used strictly under a doctor's recommendation, following a valid prescription, and when intravenous therapy is indicated for the patient's treatment protocol.

Q: Where is Krabeva 100 mg Injection manufactured and marketed?

A: Krabeva 100 mg Injection is produced in India by Biocon Biologics and is distributed to hospitals, clinics, and medical suppliers throughout the country.

Q: What is the process for obtaining Krabeva 100 mg Injection for distribution or supply?

A: Medical distributors, exporters, suppliers, traders, and wholesalers must procure Krabeva through authorized channels and ensure it is dispensed only to healthcare professionals with a valid prescription.

Q: How does using Krabeva 100 mg Injection benefit doctors and patients?

A: Doctors benefit from its ready-to-administer solution, facilitating prompt treatment. Patients receive precise intravenous therapy, which can result in more effective and timely clinical outcomes.

Tell us about your requirement